When comparing the two biomarkers in patients with neuropathy, the diagnostic accuracy of chitotriosidase was superior to that of neopterin, with an area under the curve (AUC) of 0.843 and an associated confidence interval between 0.727–0.959 (p < 0.001). This evidence concerns the gene CHIT1 and neuropathy.